Filing Details
- Accession Number:
- 0001209191-15-041252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 17:34:25
- Reporting Period:
- 2015-05-04
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 17:34:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236387 | N James Wilson | C/O Corcept Therapeutics 149 Commonwealth Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-04 | 10,000 | $1.51 | 1,711,396 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-04 | 10,000 | $5.92 | 1,701,396 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option | Disposition | 2015-05-04 | 10,000 | $0.00 | 10,000 | $1.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
230,000 | 2017-05-18 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The sale prices ranged from $5.85 to $6.01 per share.
- Fully exercisable